← Back to Search

Behavioral Intervention

Deep Brain Reorienting for Post-Traumatic Stress Disorder

Led By Ruth A Lanius, MD, PhD
Research Sponsored by Lawson Health Research Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Age between 18 and 65
Be older than 18 years old
Screening 3 weeks
Treatment Varies
Follow Up 3 months
Awards & highlights

Study Summary

This trial will test whether Deep Brain Reorienting (DBR) is an effective treatment for PTSD. Participants will be assigned to either the DBR treatment or a wait-list condition.

Who is the study for?
This trial is for English-speaking adults aged 18-65 with PTSD who might gain from short-term trauma therapy. It's not for those with implants or conditions unsafe for high-strength fMRI, significant head injuries, untreated major illnesses, neurological disorders, extensive current counseling (like exposure therapy), severe mental distress unsuitable for brief treatment, developmental disorders, bipolar or psychotic history, or recent substance abuse.Check my eligibility
What is being tested?
The study tests Deep Brain Reorienting (DBR) as a treatment for PTSD. Participants will be randomly assigned to either receive DBR therapy or placed on a wait-list as part of the control group to compare outcomes between the two sets.See study design
What are the potential side effects?
While specific side effects are not listed here due to the nature of psychological interventions like DBR being less likely to have physical side effects compared to medication-based treatments; participants may experience emotional discomfort during sessions.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
I am between 18 and 65 years old.


Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
change in PTSD symptoms from baseline as measured by the Clinician Administered PTSD Scale (CAPS) at post-treatment assessment
change in PTSD symptoms from post-treatment assessment as measured by the Clinician Administered PTSD Scale (CAPS) at follow-up assessment

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: DBR ConditionExperimental Treatment1 Intervention
Involves 8 weekly sessions of DBR treatment.
Group II: Wait-list ConditionActive Control1 Intervention
No intervention for approximately 8 weeks.

Find a Location

Who is running the clinical trial?

Lawson Health Research InstituteLead Sponsor
656 Previous Clinical Trials
413,304 Total Patients Enrolled
Canadian Institutes of Health Research (CIHR)OTHER_GOV
1,340 Previous Clinical Trials
26,452,574 Total Patients Enrolled
Ruth A Lanius, MD, PhDPrincipal InvestigatorLawson Health Research Institute
1 Previous Clinical Trials

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How can I gain access to participate in this trial?

"For this trial, 124 people aged 18 to 65 who suffer from moral injury and meet the diagnostic criteria for PTSD are being sought. Additionally, all applicants must demonstrate a potential benefit from short-term trauma therapy (as judged by study assessment) and be able to speak English fluently."

Answered by AI

What is the total number of participants enrolled in this research endeavor?

"Affirmative. Clinicaltrials.gov offers evidence that this experiment is actively enrolling test subjects, which began on 29th of September 2020 and had a most recent update on the 20th of October 2022. The trial requires 124 patients to attend one research site."

Answered by AI

Are there any remaining vacancies for this clinical experiment?

"Per the recent data on clinicaltrials.gov, this medical experiment is actively searching for participants. The trial was first uploaded to the site at the end of September 2020 and most recently revised in October 2022."

Answered by AI

Is the age limit for participating in this research project restricted to those under 55?

"This clinical trial is only available for patients aged 18 to 65. For those that do not qualify, there are 46 trials specifically designed for minors and 328 studies tailored towards elderly individuals."

Answered by AI

Who else is applying?

What state do they live in?
How old are they?
18 - 65
What site did they apply to?
London Health Sciences Centre - University Hospital
What portion of applicants met pre-screening criteria?
Met criteria
Did not meet criteria
How many prior treatments have patients received?

Why did patients apply to this trial?

Worker's compensation is fighting with my psychiatrist, who feels I need novel treatment as PE, EMDR, and CBT have had limited success for me. In the meantime, I'm looking for options outside of WCB to work towards symptom relief.
PatientReceived no prior treatments

How responsive is this trial?

Typically responds via
Most responsive sites:
  1. London Health Sciences Centre - University Hospital: < 48 hours
Average response time
  • < 2 Days
~11 spots leftby Sep 2024